147 related articles for article (PubMed ID: 26356816)
21. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
22. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
23. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.
Jiang Y; Xie X; Li Z; Wang Z; Zhang Y; Ling ZQ; Pan Y; Wang Z; Chen Y
Cancer Res; 2011 Apr; 71(8):2959-68. PubMed ID: 21385899
[TBL] [Abstract][Full Text] [Related]
24. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
25. CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling.
Xiang T; Yu F; Fei R; Qian J; Chen W
Oncol Rep; 2016 Feb; 35(2):999-1005. PubMed ID: 26719016
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
27. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
28. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
29. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
31. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Attoub S; Rivat C; Rodrigues S; Van Bocxlaer S; Bedin M; Bruyneel E; Louvet C; Kornprobst M; André T; Mareel M; Mester J; Gespach C
Cancer Res; 2002 Sep; 62(17):4879-83. PubMed ID: 12208734
[TBL] [Abstract][Full Text] [Related]
32. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation.
Edling CE; Pedersen M; Carlsson L; Rönnstrand L; Palmer RH; Hallberg B
Br J Haematol; 2007 Jan; 136(2):260-8. PubMed ID: 17156394
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
34. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
35. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
36. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
[TBL] [Abstract][Full Text] [Related]
37. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
[TBL] [Abstract][Full Text] [Related]
38. Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
Kobayashi M; Kuroki S; Tanaka Y; Moriya Y; Kozutumi Y; Uehara Y; Ono K; Tamura K; Washizu T; Bonkobara M
Eur J Haematol; 2015 Dec; 95(6):524-31. PubMed ID: 25684098
[TBL] [Abstract][Full Text] [Related]
39. Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer.
Nordgaard C; Doll S; Matos ALSA; Høeberg M; Kazi JU; Friis S; Stenvang J; Rönnstrand L; Mann M; Manuel Afonso Moreira J
Mol Oncol; 2019 Dec; 13(12):2646-2662. PubMed ID: 31545548
[TBL] [Abstract][Full Text] [Related]
40. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
